Nasdaq
RTTNews) – BioCryst Pharmaceuticals, Inc. (BCRX) Monday announced new data from an analysis of U.S. claims data of patients with hereditary angioedema (HAE…
Read More
BioCryst Pharma Reports New Real-World Data On Use Of Orladeyo In HAE Patients
RTTNews) – BioCryst Pharmaceuticals, Inc. (BCRX) Monday announced new data from an analysis of U.S. claims data of patients with hereditary angioedema (HAE…